Explore 3 Stock Ideas & Industry Insights Download Free Report

News

What's Next for Northwest Biotherapeutics, Inc (OTC:NWBO)? Its Stock Waits for the Next Big Signal

● Northwest Biotherapeutics is a clinical-stage immuno-oncology company whose lead product candidate, DCVax-L, is a personalized (autologous) dendritic-cell immunotherapy designed to treat glioblastoma multiforme, an aggressive brain cancer.

Nitish Kishor | 10 September 2026

NewCardio's (OTC:NWCI) ECG Technology Stopped Making Headlines in 2012

NewCardio, Inc. (OTC:NWCI) is a reminder that a promising medical-technology story can fade into a dormant ticker within a few short years. Once a Silicon Valley developer of computerised electrocardiogram analysis technology, NewCardio now trades as a sub-penny shell priced at a fraction of …

Nitish Kishor | 10 September 2026

Nexalin Technology (NASDAQ: NXL) Breaks Higher: What Investors Should Watch

A recent uptick in Nexalin Technology, Inc. (NASDAQ: NXL) shares came just after a major structural change to the stock. The neurostimulation-device maker completed a reverse stock split at the end of August 2026 to shore up itsNasdaqlisting, and the shares have traded on …

Nitish Kishor | 10 September 2026

Ocean Biomedical (OTC:OCEA) Stock: A Sub-Penny Name Under Pressure After Its Nasdaq Delisting

Ocean Biomedical, Inc (OTC:OCEA) is a cautionary example of how quickly a de-SPAC biotech can unravel. The shares now change hands for a fraction of a cent, and the stock's status has shifted dramatically from itsNasdaqdebut.

Nitish Kishor | 10 September 2026

NovelStem International (OTC:NSTM) Stock: A Holding Company With Almost No News Flow

Few names on the U.S. markets are as quiet as NovelStem International Corp (OTC:NSTM). The stock trades at roughly a penny, itsMarket Valueis measured in the hundreds of thousands of dollars, and its most recent verifiable press releases date back to 2022 and 2023. …

Nitish Kishor | 10 September 2026

NeOnc Technologies Holdings (NASDAQ:NTHI) Slides: What Investors Need to Know

● NeOnc Technologies Holdings fell roughly 11% in a single session, and this time the move traces to a concrete, verifiable event rather than random volatility.

Nitish Kishor | 10 September 2026

Nu-Med Plus Inc (OTC:NUMD) Slides: What Investors Need to Know

● Nu-Med Plus, incorporated in 2011, describes itself as a developer and commercialiser of medical devices, with a focus on nitric oxide generation and delivery technology aimed at respiratory and cardiovascular care.

Nitish Kishor | 10 September 2026

NUVM Goes Quiet: Why NuVim (OTC:NUVM) Could Still Be One to Watch

● NuVim built its identity years ago around functional, wellness-oriented beverages, nutrient-fortified, dairy-based drinks marketed for immune support and everyday nutrition.

Nitish Kishor | 10 September 2026

Anbio Biotechnology (NASDAQ:NNNN) Stock: What Could Break the Company's Current Standstill

Few 2025 debutants have swung as violently as Anbio Biotechnology (NASDAQ:NNNN). After listing barely eighteen months ago, the in-vitro diagnostics maker has travelled from a euphoric high above $50 to single digits, punctuated by repeatedVolatilityhalts.

Nitish Kishor | 10 September 2026

Nutranomics (OTC:NNRX) Went Quiet After a 2022 Capital Raise and Never Came Back

Nutranomics, Inc. (OTC:NNRX) is a name from the nutritional-supplement corner of the micro-cap market, and its ticker still surfaces on penny-stock screens even though the company's public reporting has fallen silent. Quoted at essentially a hundredth of a cent with aMarket Valuein the tens …

Nitish Kishor | 10 September 2026
Support

Hi! How can we help you today?

Loading…